Dalquen P, Fasel J, Mihatsch M J, Rist M, Rutishauser G
Schweiz Med Wochenschr. 1980 Feb 23;110(8):302-6.
971 samples of urine and washes of the urinary bladder in 643 patients were investigated cytologically. Urothelial carcinoma was present in 27 patients. In 11 cases the carcinoma was diagnosed by urinary cytology; 7 of the carcinomas were localized in the urinary bladder, 3 in the renal pelvis and 1 in the ureter. By contrast, all 19 tumors diagnosed in washes were localized in the urinary bladder. Diagnostic sensitivity was 100% in urine and about 75% in bladder washes. In 5 other patients cytologic diagnosis of carcinoma could not be confirmed by histology. In 4 of these, urothelial papillomas were present and in 1 patient a carcinoma of the bladder had been resected previously. Thus, the diagnostic accuracy of urinary cytology is good if essential methodological prerequisites are fulfilled. Therefore, urinary cytology appears to be an appropriate method for screening programmes in high risk patients such as phenacetin abusers. The estimated costs of a screening programme in Basel are 50 000-150 000 Swiss francs. However, a preliminary study to verify the value of such a screening programme is suggested.
对643例患者的971份尿液样本及膀胱冲洗液进行了细胞学检查。27例患者存在尿路上皮癌。11例患者的癌症通过尿液细胞学检查确诊;其中7例癌症位于膀胱,3例位于肾盂,1例位于输尿管。相比之下,通过冲洗液诊断出的19例肿瘤均位于膀胱。尿液诊断敏感性为100%,膀胱冲洗液约为75%。另外5例患者的癌症细胞学诊断未能得到组织学证实。其中4例存在尿路上皮乳头状瘤,1例患者此前已切除膀胱肿瘤。因此,若满足基本的方法学前提条件,尿液细胞学检查的诊断准确性良好。所以,尿液细胞学检查似乎是对如非那西丁滥用者等高危患者进行筛查项目的合适方法。在巴塞尔进行一项筛查项目的估计费用为5万至15万瑞士法郎。然而,建议进行一项初步研究以验证此类筛查项目的价值。